{"id":1180,"date":"2016-05-06T13:59:38","date_gmt":"2016-05-06T12:59:38","guid":{"rendered":"https:\/\/blogs.bmj.com\/sti\/?p=1180"},"modified":"2016-05-05T14:00:48","modified_gmt":"2016-05-05T13:00:48","slug":"can-a-case-be-made-for-opportunistic-testing-for-chlamydia","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/","title":{"rendered":"Can a case be made for opportunistic testing for Chlamydia?"},"content":{"rendered":"<p>Last month saw the publication of a revised <a href=\"http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/chlamydia-control-europe-guidance.pdf\">Guidance on Chlamydia Control in Europe (2016)<\/a> by the European Centre for Disease Prevention and Control.\u00a0 This replaces the earlier <a href=\"http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/0906_GUI_Chlamydia_Control_in_Europe.pdf\">Guidance on Chlamydia Control in Europe (2009)<\/a> \u2013 though the 2016 document refers the reader to the 2009 one for more detailed descriptions of the epidemiology of the infection in Europe, and of prevention programmes in the various states.\u00a0 The 2016 Guidance displays a distinct change in tone from the earlier document, reflecting greater scepticism as to the feasibility of an \u2018effective Chlamydia control strategy\u2019 and abandoning the earlier \u2018step-by-step\u2019 presentation with its suggestion of ascending levels culminating in register-based screening.\u00a0 The changes concern primarily opportunistic testing and screening (formerly levels C and D in the ascending sequence).\u00a0 These interventions are now recommended only \u2018if resources are available\u2019.<\/p>\n<p>So what sort of case can be made for Chlamydia prevention interventions that go beyond primary prevention to at-risk individuals, evidence-based case management, and partner notification?<\/p>\n<p>In favour of asymptomatic testing it is sometimes argued that the <em>sequelae<\/em> of Chlamydia such as Pelvic Inflammatory Disease (PID), ectopic pregnancy and tubal infertility largely occur in patients who have experienced only asymptomatic infection; so interventions restricted to treating symptomatic patients and their partners are likely to have limited impact on the prevention of complications (see <a href=\"http:\/\/www.bmj.com\/content\/334\/7596\/725\">Low<\/a>, and response by Joan M. Chow).\u00a0 On the other hand, it has proved very difficult, in practice, to come up with opportunistic testing interventions that can be shown to be effective (see <a href=\"http:\/\/www.bmj.com\/content\/334\/7596\/725\">Low<\/a>).\u00a0 As far as concerns the population level impact of such interventions, it seems unreasonable, on current evidence, to expect that they would ever be able to achieve sufficiently high levels of coverage.\u00a0 However, If we limit our interest to their impact at the individual level, the effectiveness of opportunistic testing turns out to be very difficult to evaluate, because insufficient is known, amongst other things, about the risk of Chlamydia progressing to complications.\u00a0 And without knowing more about the effectiveness of interventions, it is difficult to produce a robust evaluation of their cost effectiveness.<\/p>\n<p>Some attempts have been made, however.\u00a0 <a href=\"http:\/\/sti.bmj.com\/content\/91\/6\/423.abstract?sid=0fadfbbc-e7a4-414b-9448-4e499eb3ba7e\">De Wit &amp; Kretzschmar\/STIs<\/a> (D&amp;K) model various screening scenarios on the basis of data from a three year annual screening programme in an area of the Netherlands that was genuinely register-based \u2013 as opposed to the opportunistic testing undertaken by the so-called \u2018screening\u2019 programme in the UK.\u00a0 <a href=\"http:\/\/sti.bmj.com\/content\/87\/2\/156.abstract?sid=5e052fc2-d236-4b13-bf3b-61f5952cc870\">Andersen &amp; Valkengoed\/STIs<\/a> (A&amp;V) report on the Danish \u2018register\u2019 study which randomly assigned 9000 from the public register either to be invited or not invited for a Chlamydia test, and then followed up both arms for Chlamydia <em>sequelae <\/em>over a nine-year period.\u00a0 From neither study are the results particularly encouraging.\u00a0 D&amp;K estimate cost effectiveness, on the most favourable scenario, at over $50,000 per QALY; while A&amp;V report no benefit from participation in the intervention arm which received invitation to a Chlamydia test.<\/p>\n<p>As for opportunistic testing, <a href=\"http:\/\/sti.bmj.com\/content\/86\/3\/217.abstract?sid=5f0d13fb-0271-443d-b51d-babbe7160f8a\">Johnson &amp; Cassell\/STIs<\/a> (J&amp;C) compare the various institutional settings involved in UK national programme in respect to the number of tests performed and the rates of positivity \u2013 as do <a href=\"http:\/\/sti.bmj.com\/content\/early\/2015\/08\/11\/sextrans-2015-052065.abstract?sid=be530f16-654e-46b1-baa6-94a6e8cc5401\">den Heijer &amp; Dukers- Muijrers\/STIs<\/a> (d&amp;D) for the South Limburg area of the Netherlands in study on a registered based intervention (see also <a href=\"http:\/\/sti.bmj.com\/content\/early\/2016\/02\/18\/sextrans-2015-052277.extract\">Woodhall &amp; Saunders\/STIs<\/a>).\u00a0 J&amp;C remark on the relative importance for women of healthcare-based settings along with youth centres, both as regards number of tests performed and positivity.\u00a0 This happens to agree with the findings of d&amp;D who report <strong>71%<\/strong> of female positive diagnoses in healthcare settings.\u00a0 For men, non-healthcare related institutional settings were popular, but had considerably lower rates of positivity than healthcare-related settings.<\/p>\n<p>Overall, these papers seem to indicate the likely effectiveness of opportunistic testing through enhanced testing services in healthcare-related settings \u2013a solution that might be achievable without undue cost through existing health services.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Last month saw the publication of a revised Guidance on Chlamydia Control in Europe (2016) by the European Centre for Disease Prevention and Control.\u00a0 This replaces the earlier Guidance on Chlamydia Control in Europe (2009) \u2013 though the 2016 document refers the reader to the 2009 one for more detailed descriptions of the epidemiology of [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":152,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2792,1648,599],"tags":[],"class_list":["post-1180","post","type-post","status-publish","format-standard","hentry","category-chlamydia","category-chlamydia-screening","category-screening"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Can a case be made for opportunistic testing for Chlamydia? - Sexually Transmitted Infections<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Can a case be made for opportunistic testing for Chlamydia? - Sexually Transmitted Infections\" \/>\n<meta property=\"og:description\" content=\"Last month saw the publication of a revised Guidance on Chlamydia Control in Europe (2016) by the European Centre for Disease Prevention and Control.\u00a0 This replaces the earlier Guidance on Chlamydia Control in Europe (2009) \u2013 though the 2016 document refers the reader to the 2009 one for more detailed descriptions of the epidemiology of [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/\" \/>\n<meta property=\"og:site_name\" content=\"Sexually Transmitted Infections\" \/>\n<meta property=\"article:published_time\" content=\"2016-05-06T12:59:38+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Can a case be made for opportunistic testing for Chlamydia?\",\"datePublished\":\"2016-05-06T12:59:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/\"},\"wordCount\":656,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#organization\"},\"articleSection\":[\"Chlamydia\",\"Chlamydia Screening\",\"Screening\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/\",\"name\":\"Can a case be made for opportunistic testing for Chlamydia? - Sexually Transmitted Infections\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#website\"},\"datePublished\":\"2016-05-06T12:59:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/2016\\\/05\\\/06\\\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Can a case be made for opportunistic testing for Chlamydia?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/\",\"name\":\"Sexually Transmitted Infections\",\"description\":\"Discussion and suggestion space for readers of STIs\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#organization\",\"name\":\"Sexually Transmitted Infections\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/files\\\/2017\\\/10\\\/blog-logo-sti.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/files\\\/2017\\\/10\\\/blog-logo-sti.png\",\"width\":378,\"height\":34,\"caption\":\"Sexually Transmitted Infections\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/sti\\\/author\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Can a case be made for opportunistic testing for Chlamydia? - Sexually Transmitted Infections","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/","og_locale":"en_US","og_type":"article","og_title":"Can a case be made for opportunistic testing for Chlamydia? - Sexually Transmitted Infections","og_description":"Last month saw the publication of a revised Guidance on Chlamydia Control in Europe (2016) by the European Centre for Disease Prevention and Control.\u00a0 This replaces the earlier Guidance on Chlamydia Control in Europe (2009) \u2013 though the 2016 document refers the reader to the 2009 one for more detailed descriptions of the epidemiology of [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/","og_site_name":"Sexually Transmitted Infections","article_published_time":"2016-05-06T12:59:38+00:00","twitter_card":"summary_large_image","twitter_misc":{"Written by":"","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/"},"author":{"name":"","@id":""},"headline":"Can a case be made for opportunistic testing for Chlamydia?","datePublished":"2016-05-06T12:59:38+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/"},"wordCount":656,"publisher":{"@id":"https:\/\/blogs.bmj.com\/sti\/#organization"},"articleSection":["Chlamydia","Chlamydia Screening","Screening"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/","url":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/","name":"Can a case be made for opportunistic testing for Chlamydia? - Sexually Transmitted Infections","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/sti\/#website"},"datePublished":"2016-05-06T12:59:38+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/sti\/2016\/05\/06\/can-a-case-be-made-for-opportunistic-testing-for-chlamydia\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/sti\/"},{"@type":"ListItem","position":2,"name":"Can a case be made for opportunistic testing for Chlamydia?"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/sti\/#website","url":"https:\/\/blogs.bmj.com\/sti\/","name":"Sexually Transmitted Infections","description":"Discussion and suggestion space for readers of STIs","publisher":{"@id":"https:\/\/blogs.bmj.com\/sti\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/sti\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/sti\/#organization","name":"Sexually Transmitted Infections","url":"https:\/\/blogs.bmj.com\/sti\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/sti\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/sti\/files\/2017\/10\/blog-logo-sti.png","contentUrl":"https:\/\/blogs.bmj.com\/sti\/files\/2017\/10\/blog-logo-sti.png","width":378,"height":34,"caption":"Sexually Transmitted Infections"},"image":{"@id":"https:\/\/blogs.bmj.com\/sti\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/blogs.bmj.com\/sti\/author\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/posts\/1180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/users\/152"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/comments?post=1180"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/posts\/1180\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/media?parent=1180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/categories?post=1180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/sti\/wp-json\/wp\/v2\/tags?post=1180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}